GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (BSP:A1LG34) » Definitions » Valuation Rank

Align Technology (BSP:A1LG34) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Align Technology Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Align Technology Valuation Rank Related Terms

Thank you for viewing the detailed overview of Align Technology's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Align Technology (BSP:A1LG34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Align Technology Inc (BSP:A1LG34) » Definitions » Valuation Rank
Comparable Companies
STE ZBH BRKR SWAV PODD BIO PEN MASI GMED INSP TSE:5212 ABT SYK MDT BSX EW DXCM SZSE:300760 XAMS:PHIA XSWX:SOON
Traded in Other Exchanges
ALGN:USA ALGN:Mexico AFW:Germany AFW:Germany
Address
410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85281
Website
https://www.aligntech.com
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.